Liquid Biopsy in <i>EGFR</i>-Mutated Advanced NSCLC from T790M to <i>MET</i> Amplification: Clinical Implications and Possibilities in the Resistance Setting

Liquid Biopsy in <i>EGFR</i>-Mutated Advanced NSCLC from T790M to <i>MET</i> Amplification: Clinical Implications and Possibilities in the Resistance Setting

According to the ESMO and ASCO clinical guidelines, the main role of liquid biopsy in <i>EGFR</i>+ advanced NSCLC patients is represented by T790M detection after erlotinib/gefitinib/afatinib progression. However, the general international expert consensus regards osimertinib as the pref...

Full description

Bibliographic Details
Main Authors: Luigi Della Gravara, Ciro Battiloro, Aniello Avellino, Francesca Caputo, Carmine D’Aniello, Danilo Rocco
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Journal of Molecular Pathology
Subjects:
NSCLC
<i>EGFR</i>
<i>MET</i>
osimertinib
liquid biopsy
NGS
Online Access:https://www.mdpi.com/2673-5261/4/2/9

Internet

https://www.mdpi.com/2673-5261/4/2/9

Similar Items